SLE serum induces classical caspase-dependent apoptosis independent of death receptors

被引:25
作者
Bengtsson, Anders A. [1 ]
Gullstrand, Birgitta [2 ]
Truedsson, Lennart [2 ]
Sturfelt, Gunnar [1 ]
机构
[1] Univ Lund Hosp, Dept Rheumatol, SE-22185 Lund, Sweden
[2] Lund Univ, Dept Lab Med, S-22100 Lund, Sweden
关键词
SLE; apoptosis; serum; death receptors; caspases;
D O I
10.1016/j.clim.2007.10.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The main source of autoantigens in systemic lupus erythematosus (SLE) is most likely apoptotic material. We have previously shown that sera from SLE patients can induce apoptosis in monocytes and lymphocytes, and here we characterized mechanisms of apoptosis induced by SLE serum. SLE serum seems to induce caspase-dependent classical apoptosis since cells exposed to SLE serum displayed morphology consistent with classical apoptosis as demonstrated by confocal microscopy, and pan-caspase inhibitor Z-VAD.fmk significantly reduced SLE serum-induced apoptosis. Death-receptor-independent pathways seemed to be involved since SLE serum induced apoptosis equally in FADD-mutant and wild-type Jurkat cell lines, and blocking of Fas and TNFR1 did not reduce apoptosis induction. Importantly, apoptosis was significantly reduced in a Bcl-2 overexpressing Jurkat cell tine indicating involvement of mitochondrial pathways. Thus, based on morphology and caspase inhibition experiments, we have demonstrated that SLE serum induce classical caspase-dependent apoptosis, and this was independent of death receptor pathways. (C) 2007 Elsevier Inc. All. rights reserved.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 28 条
[1]
Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load? [J].
Bengtsson, AA ;
Sturfelt, G ;
Gullstrand, B ;
Truedsson, L .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 135 (03) :535-543
[2]
Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity [J].
Bijl, M ;
Horst, G ;
Limburg, PC ;
Kallenberg, CGM .
LUPUS, 2001, 10 (12) :866-872
[3]
AUTOANTIGENS TARGETED IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARE CLUSTERED IN 2 POPULATIONS OF SURFACE-STRUCTURES ON APOPTOTIC KERATINOCYTES [J].
CASCIOLAROSEN, LA ;
ANHALT, G ;
ROSEN, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1317-1330
[4]
Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity [J].
Courtney, PA ;
Crockard, AD ;
Williamson, K ;
McConnell, J ;
Kennedy, RJ ;
Bell, AL .
LUPUS, 1999, 8 (07) :508-513
[5]
Death receptors in chemotherapy and cancer [J].
Debatin, KM ;
Krammer, PH .
ONCOGENE, 2004, 23 (16) :2950-2966
[6]
EMLEN W, 1994, J IMMUNOL, V152, P3685
[7]
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis [J].
Engels, IH ;
Stepczynska, A ;
Stroh, C ;
Lauber, K ;
Berg, C ;
Schwenzer, R ;
Wajant, H ;
Jänicke, RUU ;
Porter, AG ;
Belka, C ;
Gregor, M ;
Schulze-Osthoff, K ;
Wesselborg, S .
ONCOGENE, 2000, 19 (40) :4563-4573
[8]
Impaired clearance of dying cells in systemic lupus erythematosus [J].
Gaipl, US ;
Voll, RE ;
Sheriff, A ;
Franz, S ;
Kalden, JR ;
Herrmann, M .
AUTOIMMUNITY REVIEWS, 2005, 4 (04) :189-194
[9]
Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO
[10]
2-H